AccessibilityHelpAbout Us
Surgical Science Sweden Ab (publ) logo

Surgical Science Sweden Ab (publ)(OTC) SUSRF

Market Cap$265.34MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2021)-63%
5 Year-62%
1 Year-50%
1 Month+30%
$5.20
+4.00%
+0.20Today
Surgical Science Sweden Ab (publ) last closing stock price
MetricPriceDate
Last closeUSD 5.202026-08-24
Surgical Science Sweden Ab (publ) stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+30%USD 4.002026-07-20
1 month+30%USD 4.002026-07-20
3 month+30%USD 4.002026-05-22
Year to date+52.49%USD 3.412025-12-29
1 year-50.24%USD 10.452025-08-12
3 year-62.99%USD 14.052023-08-25
5 year-61.9%USD 13.652021-05-28
Since inception-62.94%USD 14.032021-01-21

Surgical Science Sweden Ab (publ) Financials at a Glance

Market Cap

$265.34MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

SEK 1.02B

Net Income (TTM)

SEK 92.87M

EPS (TTM)

$0.19

P/E Ratio

26.68

Dividend

$0.00

Beta (Volatility)

-0.05 (Low)

Price

$5.20

Volume

200

Open

$5.20

Previous Close

$5.20

Daily Range

$5.20 - $5.20

52-Week Range

$2.84 - $9.95

Estimated Earnings Date

Nov 12, 2026

SUSRF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Surgical Science Sweden Ab (publ)

Surgical Science Sweden AB specializes in developing advanced simulators for laparoscopic medical training. The company offers innovative solutions that enhance surgical education and improve patient outcomes through realistic training experiences.

Products and Services
  • LapSim: A simulator for various laparoscopic procedures
  • EndoSim: Focused on endoscopy simulation for training
  • TeamSim: Enhances collaboration training within surgical teams
Growth Outlook
  • Revenue increased to 252 million SEK in Q2 2026, up from 235 million SEK in Q1 2026
  • Net income rose to 20.7 million SEK in Q2 2026, reflecting strong operational performance
  • Cash and cash equivalents stood at 652 million SEK, indicating robust liquidity
Financial Highlights
  • Gross profit margin of 61.3% in Q2 2026 demonstrates effective cost management
  • Operating income reached 43.3 million SEK in Q2 2026, showcasing operational efficiency
  • Current ratio of 4.24 indicates strong short-term financial health
AI Generated • Aug 29, 2026

Industry

Healthcare Equipment and Supplies

Sector

Health Care

Employees

319

CEO

Tom Englund

Website

www.surgical-science.com

Headquarters

Gothenburg, VG 412 50, SE

SUSRF Financials

Key Financial Metrics (TTM)

Gross Margin

62.24%

Operating Margin

13.77%

Net Income Margin

9.11%

Return on Equity

2.12%

Return on Capital

2.55%

Return on Assets

1.87%

Earnings Yield

3.75%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$265.34MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

51.03M

Volume

200

Avg. Volume

21.032

Financials (TTM)

Gross Profit

SEK 634.67M

Operating Income

SEK 140.31M

EBITDA

SEK 212.45M

Operating Cash Flow

SEK 148.82M

Capital Expenditure

-SEK 42.99M

Free Cash Flow

SEK 105.82M

Cash & ST Invst.

SEK 652.76M

Total Debt

SEK 2.83M

Surgical Science Sweden Ab (publ) Performance Analysis

Surgical Science Sweden Ab (publ) annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31SEK 79,303,20785.6%
20232023-12-31SEK 83,162,9304.9%
20242024-12-31SEK 83,619,5500.5%
20252025-12-31SEK 101,182,06521.0%
Surgical Science Sweden Ab (publ) sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-3026.0%
Q42025-12-311.7%
Q12026-03-31-12.2%
Q22026-06-307.2%
Surgical Science Sweden Ab (publ) annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31SEK 0.3654.9%
20232023-12-31SEK 0.4318.6%
20242024-12-31SEK 0.24-43.6%
20252025-12-31SEK 0.13-45.3%
Surgical Science Sweden Ab (publ) sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-30202.6%
Q42025-12-3162.5%
Q12026-03-31-44.6%
Q22026-06-3013.9%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

SEK 252.34M

+20.6%

Gross Profit

SEK 154.65M

+13.4%

Gross Margin

61.29%

N/A

Market Cap

$265.34MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$847.72K

N/A

Employees

313

N/A

Net Income

SEK 20.67M

+203.0%

EBITDA

SEK 64.82M

+389.6%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

SEK 652.76M

+7.0%

Total Debt

SEK 2.83M

+72.3%

Accounts Receivable

SEK 207.95M

-26.6%

Inventory

SEK 232.16M

+12.4%

Long Term Debt

SEK 2.83M

+72.3%

Short Term Debt

SEK 0.00

-100.0%

Return on Assets

1.87%

N/A

Return on Invested Capital

3.01%

N/A

Free Cash Flow

SEK 7.28M

+100.8%

Operating Cash Flow

SEK 15.18M

-6.5%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
BOVNFBioInvent International AB (publ)
$3.29+0.00%
VHIBFVitalhub Corp.
$5.40-1.28%
COGZFCogstate Limited
$2.11+0.00%
PTCHFPureTech Health plc
$1.65+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
ACVAACV Auctions
$10.43+0.44%
TNONTenon Medical
$9.47+0.79%
ETHAiShares Ethereum Trust - iShares Ethereum Trust ETF
$19.60+0.06%
ORCLOracle
$153.85+0.01%

Questions About SUSRF

What is the current price of Surgical Science Sweden Ab (publ)?

Surgical Science Sweden Ab (publ) is trading at $5.20 per share.

What is the 52-week range for Surgical Science Sweden Ab (publ)?

Over the past 52 weeks, Surgical Science Sweden Ab (publ) has traded between $2.84 and $9.95.

How much debt does Surgical Science Sweden Ab (publ) have?

As of the most recent reporting period, Surgical Science Sweden Ab (publ) reported total debt of SEK 295.20K.

How much cash does Surgical Science Sweden Ab (publ) have on hand?

Surgical Science Sweden Ab (publ) reported SEK 68.03M in cash and cash equivalents in its most recent financial results.

What is Surgical Science Sweden Ab (publ)’s dividend yield?

Surgical Science Sweden Ab (publ) does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services